Maxim A Moroz1, Hanwen Zhang1, Jason Lee2, Ekaterina Moroz3, Juan Zurita1, Larissa Shenker1, Inna Serganova3, Ronald Blasberg4, Vladimir Ponomarev5. 1. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. 2. Crump Institute for Molecular Imaging, University of California, Los Angeles, California. 3. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; and. 4. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; and Sloan Kettering Institute Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. 5. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Sloan Kettering Institute Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York ponomarv@mskcc.org.
Abstract
UNLABELLED: Monitoring genetically altered T cells is an important component of adoptive T cell therapy in patients, and the ability to visualize their trafficking/targeting, proliferation/expansion, and retention/death using highly sensitive reporter systems that do not induce an immunologic response would provide useful information. Therefore, we focused on human reporter gene systems that have the potential for translation to clinical studies. The objective of the in vivo imaging studies was to determine the minimum number of T cells that could be visualized with the different nuclear reporter systems. We determined the imaging sensitivity (lower limit of T cell detection) of each reporter using appropriate radiolabeled probes for PET or SPECT imaging. METHODS: Human T cells were transduced with retroviral vectors encoding for the human norepinephrine transporter (hNET), human sodium-iodide symporter (hNIS), a human deoxycytidine kinase double mutant (hdCKDM), and herpes simplex virus type 1 thymidine kinase (hsvTK) reporter genes. After viability and growth were assessed, 10(5) to 3 × 10(6) reporter T cells were injected subcutaneously on the shoulder area. The corresponding radiolabeled probe was injected intravenously 30 min later, followed by sequential PET or SPECT imaging. Radioactivity at the T cell injection sites and in the thigh (background) was measured. RESULTS: The viability and growth of experimental cells were unaffected by transduction. The hNET/meta-(18)F-fluorobenzylguanidine ((18)F-MFBG) reporter system could detect less than 1 × 10(5) T cells because of its high uptake in the transduced T cells and low background activity. The hNIS/(124)I-iodide reporter system could detect approximately 1 × 10(6) T cells; (124)I-iodide uptake at the T cell injection site was time-dependent and associated with high background. The hdCKDM/2'-(18)F-fluoro-5-ethyl-1-β-d-arabinofuranosyluracil ((18)F-FEAU) and hsvTK/(18)F-FEAU reporter systems detected approximately 3 × 10(5) T cells, respectively. (18)F-FEAU was a more efficient probe (higher uptake, lower background) than (124)I-1-(2-deoxy-2-fluoro-1-d-arabinofuranosyl)-5-iodouracil for both hdCKDM and hsvTK. CONCLUSION: A comparison of different reporter gene-reporter probe systems for imaging of T cell number was performed, and the hNET/(18)F-MFBG PET reporter system was found to be the most sensitive and capable of detecting approximately 35-40 × 10(3) T cells at the site of T cell injection in the animal model.
UNLABELLED: Monitoring genetically altered T cells is an important component of adoptive T cell therapy in patients, and the ability to visualize their trafficking/targeting, proliferation/expansion, and retention/death using highly sensitive reporter systems that do not induce an immunologic response would provide useful information. Therefore, we focused on human reporter gene systems that have the potential for translation to clinical studies. The objective of the in vivo imaging studies was to determine the minimum number of T cells that could be visualized with the different nuclear reporter systems. We determined the imaging sensitivity (lower limit of T cell detection) of each reporter using appropriate radiolabeled probes for PET or SPECT imaging. METHODS:Human T cells were transduced with retroviral vectors encoding for the humannorepinephrine transporter (hNET), humansodium-iodide symporter (hNIS), a human deoxycytidine kinase double mutant (hdCKDM), and herpes simplex virus type 1thymidine kinase (hsvTK) reporter genes. After viability and growth were assessed, 10(5) to 3 × 10(6) reporter T cells were injected subcutaneously on the shoulder area. The corresponding radiolabeled probe was injected intravenously 30 min later, followed by sequential PET or SPECT imaging. Radioactivity at the T cell injection sites and in the thigh (background) was measured. RESULTS: The viability and growth of experimental cells were unaffected by transduction. The hNET/meta-(18)F-fluorobenzylguanidine ((18)F-MFBG) reporter system could detect less than 1 × 10(5) T cells because of its high uptake in the transduced T cells and low background activity. The hNIS/(124)I-iodide reporter system could detect approximately 1 × 10(6) T cells; (124)I-iodide uptake at the T cell injection site was time-dependent and associated with high background. The hdCKDM/2'-(18)F-fluoro-5-ethyl-1-β-d-arabinofuranosyluracil ((18)F-FEAU) and hsvTK/(18)F-FEAU reporter systems detected approximately 3 × 10(5) T cells, respectively. (18)F-FEAU was a more efficient probe (higher uptake, lower background) than (124)I-1-(2-deoxy-2-fluoro-1-d-arabinofuranosyl)-5-iodouracil for both hdCKDM and hsvTK. CONCLUSION: A comparison of different reporter gene-reporter probe systems for imaging of T cell number was performed, and the hNET/(18)F-MFBG PET reporter system was found to be the most sensitive and capable of detecting approximately 35-40 × 10(3) T cells at the site of T cell injection in the animal model.
Authors: Kurt R Zinn; Tandra R Chaudhuri; Victor N Krasnykh; Donald J Buchsbaum; Natalya Belousova; William E Grizzle; David T Curiel; Buck E Rogers Journal: Radiology Date: 2002-05 Impact factor: 11.105
Authors: S Yaghoubi; J R Barrio; M Dahlbom; M Iyer; M Namavari; N Satyamurthy; R Goldman; H R Herschman; M E Phelps; S S Gambhir Journal: J Nucl Med Date: 2001-08 Impact factor: 10.057
Authors: Masao Miyagawa; Moritz Beyer; Bettina Wagner; Martina Anton; Christine Spitzweg; Bernd Gansbacher; Markus Schwaiger; Frank M Bengel Journal: Cardiovasc Res Date: 2005-01-01 Impact factor: 10.787
Authors: Seok Rye Choi; Zhi-Ping Zhuang; Ann-Marie Chacko; Paul D Acton; Juri Tjuvajev-Gelovani; Mikhai Doubrovin; David C K Chu; Hank F Kung Journal: Acad Radiol Date: 2005-07 Impact factor: 3.173
Authors: Juri Gelovani Tjuvajev; Mikhail Doubrovin; Timothy Akhurst; Shangde Cai; Julius Balatoni; Mian M Alauddin; Ronald Finn; William Bornmann; Howard Thaler; Peter S Conti; Ronald G Blasberg Journal: J Nucl Med Date: 2002-08 Impact factor: 10.057
Authors: Purnima Dubey; Helen Su; Nona Adonai; Shouying Du; Antonio Rosato; Jonathan Braun; Sanjiv S Gambhir; Owen N Witte Journal: Proc Natl Acad Sci U S A Date: 2003-01-23 Impact factor: 11.205
Authors: Vladimir Ponomarev; Michael Doubrovin; Aleksander Shavrin; Inna Serganova; Tatiana Beresten; Ludmila Ageyeva; Changde Cai; Julius Balatoni; Mian Alauddin; Juri Gelovani Journal: J Nucl Med Date: 2007-04-27 Impact factor: 10.057
Authors: Guenther Koehne; Mikhail Doubrovin; Ekaterina Doubrovina; Pat Zanzonico; Humilidad F Gallardo; Anna Ivanova; Julius Balatoni; Julie Teruya-Feldstein; Glenn Heller; Chad May; Vladimir Ponomarev; Shutian Ruan; Ronald Finn; Ronald G Blasberg; William Bornmann; Isabelle Riviere; Michel Sadelain; Richard J O'Reilly; Steven M Larson; Juri G Gelovani Tjuvajev Journal: Nat Biotechnol Date: 2003-03-24 Impact factor: 54.908
Authors: Simone Krebs; Afruja Ahad; Lukas M Carter; Justin Eyquem; Christian Brand; Meghan Bell; Vladimir Ponomarev; Thomas Reiner; Claude F Meares; Stephen Gottschalk; Michel Sadelain; Steven M Larson; Wolfgang A Weber Journal: J Nucl Med Date: 2018-06-14 Impact factor: 10.057
Authors: Yogindra Vedvyas; Enda Shevlin; Marjan Zaman; Irene M Min; Alejandro Amor-Coarasa; Spencer Park; Susan Park; Keon-Woo Kwon; Turner Smith; Yonghua Luo; Dohyun Kim; Young Kim; Benedict Law; Richard Ting; John Babich; Moonsoo M Jin Journal: JCI Insight Date: 2016-11-17
Authors: Mark A Sellmyer; Iljung Lee; Catherine Hou; Brian P Lieberman; Chenbo Zeng; David A Mankoff; Robert H Mach Journal: Mol Ther Date: 2017-01-04 Impact factor: 11.454
Authors: Piotr Jurgielewicz; Stefan Harmsen; Elizabeth Wei; Michael H Bachmann; Richard Ting; Omer Aras Journal: Cell Mol Life Sci Date: 2017-07-03 Impact factor: 9.261
Authors: Mark A Sellmyer; Sarah A Richman; Katheryn Lohith; Catherine Hou; Chi-Chang Weng; Robert H Mach; Roddy S O'Connor; Michael C Milone; Michael D Farwell Journal: Mol Ther Date: 2019-10-15 Impact factor: 11.454